Ampio Pharmaceuticals (AMPE) Weaker After Negative Blog Post
Tweet
Share
E-mailGet Alerts AMPE Hot Sheet
Join SI Premium – FREE
Shares of recent momentum movers Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) are seeing some pressure mid-day following a negative blog at SeekingAlpha entitiled: "Ampio Pharmaceuticals' Pipeline Doesn't Look Good".
The blog states that a recent article touting the stock, "has many fallacies in it such as talking up Ampio's pipeline and implying that a pre-IND meeting is a big deal."
Shares of Ampio were down 3.5 percent at last check.
The blog states that a recent article touting the stock, "has many fallacies in it such as talking up Ampio's pipeline and implying that a pre-IND meeting is a big deal."
Shares of Ampio were down 3.5 percent at last check.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic hires Google chip veteran as it pushed into hardware - Bloomberg
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
